Dr. Christopher Anzalone, CEO, announced Arrowhead’s first FDA approval for REDEMPLO, marking a major milestone as the company transitions to a commercial-stage entity. He stated that "REDEMPLO is the ...

Bulletin: ...WIND ADVISORY REMAINS IN EFFECT FROM 1 AM FRIDAY TO 1 AM EST SATURDAY... * WHAT...Southwest winds 20 to 30 mph with gusts up to 45 mph expected Thursday ...

PASADENA - Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to plozasiran for treating adults with ...

Bulletin: ...WINTER WEATHER ADVISORY REMAINS IN EFFECT FROM 6 AM TO 6 PM EST WEDNESDAY... * WHAT...Mixed precipitation expected. Total snow accumulations between 1 ...